Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $-103.05M.
ENTERPRISE VALUE (EV)
$-103.05M
TScan Therapeutics, Inc.
Market Cap
$16.82M
Enterprise Value (EV)
$-103.05M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| TScan Therapeutics, Inc. (TCRX) | $16.82M | $-103.05M |
| Marker Therapeutics, Inc. (MRKR)vs › | $16.84M | $5.51M |
| Palatin Technologies, Inc. (PTN)vs › | $16.74M | $9.47M |
| Bionano Genomics, Inc. (BNGO)vs › | $16.64M | $19.61M |
| PAVmed Inc. (PAVM)vs › | $17.07M | $30.36M |
| Dyadic International, Inc. (DYAI)vs › | $16.52M | $20.14M |
| Lipocine Inc. (LPCN)vs › | $17.31M | $12.33M |
| Cosmos Health Inc. (COSM)vs › | $17.39M | $31.57M |
| BioCardia, Inc. (BCDA)vs › | $15.78M | $11.95M |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.68M | $20.98M |
Market Cap
$16.82M
Total Debt
$32.53M
Cash
$152.41M
Enterprise Value
$-103.05M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
